Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

KRX:007570 Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	235,777	205,533	281,258	349,981	510,655	1,197,901
Market Cap Growth	-30.89%	-26.92%	-19.64%	-31.46%	-57.37%	191.80%
Enterprise Value	342,224	341,070	394,941	436,337	605,360	1,322,774
Last Close Price	13120.00	11410.00	15441.15	18905.81	27200.55	63349.14
PE Ratio	20.82	21.04	-	18.48	36.39	110.11
Forward PE	-	49.90	49.90	49.90	49.90	49.90
PS Ratio	0.87	0.76	1.06	1.41	2.11	3.49
PB Ratio	0.97	0.85	1.22	1.47	2.25	4.89
P/TBV Ratio	1.00	0.88	1.26	1.51	2.32	5.92
P/FCF Ratio	-	-	32.19	180.62	13.07	25.32
P/OCF Ratio	1998.63	36.60	19.24	59.49	9.93	20.84
EV/Sales Ratio	1.26	1.27	1.48	1.76	2.50	3.85
EV/EBITDA Ratio	14.28	16.38	13.93	16.77	22.92	28.29
EV/EBIT Ratio	23.45	31.01	24.11	30.62	39.86	38.79
EV/FCF Ratio	-9.22	-	45.21	225.19	15.50	27.96
Debt / Equity Ratio	0.47	0.45	0.32	0.31	0.43	0.42
Debt / EBITDA Ratio	5.29	5.17	2.56	2.85	3.73	2.20
Debt / FCF Ratio	-	-	8.32	38.24	2.52	2.18
Asset Turnover	0.60	0.65	0.67	0.60	0.56	0.78
Inventory Turnover	2.36	2.79	2.96	3.46	3.40	3.17
Quick Ratio	0.40	0.39	0.47	0.46	0.59	0.60
Current Ratio	0.85	0.80	0.89	0.82	0.81	0.92
Return on Equity (ROE)	4.80%	4.45%	-0.87%	8.53%	6.25%	9.21%
Return on Assets (ROA)	1.69%	1.67%	2.57%	2.17%	2.21%	4.86%
Return on Capital (ROIC)	2.16%	2.11%	3.33%	2.79%	2.82%	6.10%
Return on Capital Employed (ROCE)	4.30%	4.00%	6.50%	5.50%	6.00%	13.00%
Earnings Yield	4.86%	4.99%	-0.86%	5.54%	2.75%	0.91%
FCF Yield	-15.75%	-15.85%	3.11%	0.55%	7.65%	3.95%
Dividend Yield	1.14%	1.31%	-	-	-	-
Payout Ratio	24.07%	29.00%	-	20.34%	16.74%	45.05%
Buyback Yield / Dilution	-1.18%	0.26%	0.59%	0.44%	-	-
Total Shareholder Return	-0.04%	1.58%	0.59%	0.44%	-	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.